Mobocertinib (TAK-788) in epidermal growth factor receptor gene (EGFR) exon 20 insertion mutation-positive (EGFRex20ins+) metastatic non-small cell lung cancer (mNSCLC): Results from the platinum-pretreated patients (PPP) cohort of a phase 1/2 study Meeting Abstract


Authors: Popat, S.; Ramalingam, S.; Kim, T. M.; Yang, J.; Riely, G.; Mekhail, T.; Nguyen, D.; Garcia Campelo, M. R.; Felip, E.; Spira, A.; Piotrowska, Z.; Bazhenova, L.; Vincent, S.; Jin, S.; Griffin, C.; Diderichsen, P.; Gupta, N.; Bunn, V.; Lin, J. C.; Lin, H.; Churchill, E.; Mehta, M.; Zhou, C.; Jänne, , P.
Abstract Title: Mobocertinib (TAK-788) in epidermal growth factor receptor gene (EGFR) exon 20 insertion mutation-positive (EGFRex20ins+) metastatic non-small cell lung cancer (mNSCLC): Results from the platinum-pretreated patients (PPP) cohort of a phase 1/2 study
Meeting Title: 20th Annual Conference of the British Thoracic Oncology Group (BTOG)
Journal Title: Lung Cancer
Volume: 165
Issue: Suppl. 1
Meeting Dates: 2022 Jan 27-28
Meeting Location: Virtual
ISSN: 0169-5002
Publisher: Elsevier Ireland Ltd.  
Date Published: 2022-03-01
Start Page: S30
End Page: S31
Language: English
ACCESSION: WOS:000774314500065
PROVIDER: wos
DOI: 10.1016/S0169-5002(22)00111-8
Notes: Meeting Abstract: 64 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely